We recently showed that 35% of DLBCL express CCNE in >20% of tumor cells (Fig. 4D) despite the general lack of CCNE gene amplification (Tzankov et al. 2006), a constellation similar to that in classical Hodgkin lymphoma (Tzankov et al. 2003b). This evidence concerns the gene CCNE1 and Hodgkins lymphoma.